Volk, Hans-Dieter

Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment

Schulte-Schrepping, J., Reusch, N., Paclik, D., Baßler, K., Schlickeiser, S., Zhang, B., Krämer, B., Krammer, T., Brumhard, S., Bonaguro, L., et al. (2020) · Cell

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 1,461

Monocyte deactivation in septic patients: Restoration by IFN-γ treatment

Döcke, W.-D., Randow, F., Syrbe, U., Krausch, D., Asadullah, K., Reinke, P., Volk, H.-D., & Kox, W. (1997) · Nature Medicine

Sepsis Diagnosis and TreatmentImmune Response and Inflammation

Cited by 1,190

Endotoxin and immune activation in chronic heart failure: a prospective cohort study

Niebauer, J., Volk, H.-D., Kemp, M., Dominguez, M., Schumann, R. R., Rauchhaus, M., Poole-Wilson, P. A., Coats, A. J., & Anker, S. D. (1999) · The Lancet

Heart Failure Treatment and ManagementSepsis Diagnosis and Treatment

Cited by 877

A circadian clock in macrophages controls inflammatory immune responses

Keller, M., Mazuch, J., Abraham, U., Eom, G. D., Herzog, E. D., Volk, H.-D., Kramer, A., & Maier, B. (2009) · Proceedings of the National Academy of Sciences

Circadian rhythm and melatoninSleep and Work-Related Fatigue

Cited by 843

Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure

Rauchhaus, M., Doehner, W., Francis, D. P., Davos, C., Kemp, M., Liebenthal, C., Niebauer, J., Hooper, J., Volk, H.-D., Coats, A. J. S., et al. (2000) · Circulation

Heart Failure Treatment and ManagementCardiac Fibrosis and Remodeling

Cited by 810

MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis

Kotlyarov, A., Neininger, A., Schubert, C., Eckert, R., Birchmeier, C., Volk, H.-D., & Gaestel, M. (1999) · Nature Cell Biology

NF-κB Signaling PathwaysImmune Response and Inflammation

Cited by 763

Altered intestinal function in patients with chronic heart failure

Sandek, A., Bauditz, J., Swidsinski, A., Buhner, S., Weber-Eibel, J., von Haehling, S., Schroedl, W., Karhausen, T., Doehner, W., Rauchhaus, M., et al. (2007) · Journal of the American College of Cardiology

Gastrointestinal motility and disordersHeart Failure Treatment and Management

Cited by 661

Immunologic and Hemodynamic Effects of “Low-Dose” Hydrocortisone in Septic Shock: A Double-Blind, Randomized, Placebo-controlled, Crossover Study

Keh, D., Boehnke, T., Weber-Cartens, S., Schulz, C., Ahlers, O., Bercker, S., Volk, H.-D., Doecke, W.-D., Falke, K. J., & Gerlach, H. (2003) · American Journal of Respiratory and Critical Care Medicine

Adrenal Hormones and DisordersSepsis Diagnosis and Treatment

Cited by 600

Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines

Moll, G., Ankrum, J. A., Kamhieh-Milz, J., Bieback, K., Ringdén, O., Volk, H.-D., Geissler, S., & Reinke, P. (2019) · Trends in Molecular Medicine

Mesenchymal stem cell researchHematopoietic Stem Cell Transplantation

Cited by 440

High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population

Wagner, D. L., Amini, L., Wendering, D. J., Burkhardt, L.-M., Akyüz, L., Reinke, P., Volk, H.-D., & Schmueck-Henneresse, M. (2019) · Nature Medicine

CRISPR and Genetic EngineeringT-cell and B-cell Immunology

Cited by 399

Elevated soluble CD14 receptors and altered cytokines in chronic heart failure

Anker, S. D., Egerer, K. R., Volk, H.-D., Kox, W. J., Poole-Wilson, P. A., & Coats, A. J. S. (1997) · The American Journal of Cardiology

Heart Failure Treatment and ManagementSepsis Diagnosis and Treatment

Cited by 392

Cytomegalovirus reactivation and tumour necrosis factor

Döcke, W. D., Fietze, E., Syrbe, U., von Baehr, R., Volk, H. D., Prösch, S., Kimel, V., Krüger, D. H., Zuckermann, H., & Klug, C. (1994) · The Lancet

Cytomegalovirus and herpesvirus researchHerpesvirus Infections and Treatments

Cited by 268

Stimulation of the Human Cytomegalovirus IE Enhancer/Promoter in HL-60 Cells by TNFα Is Mediated via Induction of NF-κB

Prösch, S., Staak, K., Stein, J., Liebenthal, C., Stamminger, T., Volk, H.-D., & Krüger, D. H. (1995) · Virology

Cytomegalovirus and herpesvirus researchNF-κB Signaling Pathways

Cited by 188

Toward an optimized process for clinical manufacturing of CAR-treg cell therapy

Fritsche, E., Volk, H.-D., Reinke, P., & Abou-El-Enein, M. (2020) · Trends in Biotechnology

CAR-T cell therapy researchT-cell and B-cell Immunology

Cited by 97

Human immune responses to porcine xenogeneic matrices and their extracellular matrix constituents in vitro

Bayrak, A., Tyralla, M., Ladhoff, J., Schleicher, M., Stock, U. A., Volk, H.-D., & Seifert, M. (2010) · Biomaterials

Tissue Engineering and Regenerative MedicineXenotransplantation and immune response

Cited by 96

Good Manufacturing Practices (GMP) manufacturing of advanced therapy medicinal products: a novel tailored model for optimizing performance and estimating costs

Abou-El-Enein, M., Römhild, A., Kaiser, D., Beier, C., Bauer, G., Volk, H.-D., & Reinke, P. (2013) · Cytotherapy

Pharmaceutical Economics and PolicyBiomedical Ethics and Regulation

Cited by 86

Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome

Loebel, M., Strohschein, K., Giannini, C., Koelsch, U., Bauer, S., Doebis, C., Thomas, S., Unterwalder, N., von Baehr, V., Reinke, P., et al. (2014) · PLoS ONE

Fibromyalgia and Chronic Fatigue Syndrome ResearchViral-associated cancers and disorders

Cited by 86

Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edited CAR T cells

Glaser, V., Flugel, C., Kath, J., Du, W., Drosdek, V., Franke, C., Stein, M., Pruß, A., Schmueck-Henneresse, M., Volk, H.-D., et al. (2023) · Genome biology

CRISPR and Genetic EngineeringCAR-T cell therapy research

Cited by 65

Putting a price tag on novel autologous cellular therapies

Abou-El-Enein, M., Bauer, G., Medcalf, N., Volk, H.-D., & Reinke, P. (2016) · Cytotherapy

Pharmaceutical Economics and PolicyCAR-T cell therapy research

Cited by 44

Stromal Cells Act as Guardians for Endothelial Progenitors by Reducing Their Immunogenicity After Co-Transplantation

Souidi, N., Stolk, M., Rudeck, J., Strunk, D., Schallmoser, K., Volk, H.-D., & Seifert, M. (2017) · Stem Cells

Mesenchymal stem cell researchHematopoietic Stem Cell Transplantation

Cited by 32

Sequential Targeting of CD52 and TNF Allows Early Minimization Therapy in Kidney Transplantation: From a Biomarker to Targeting in a Proof-Of-Concept Trial

Viklicky, O., Hruba, P., Tomiuk, S., Schmitz, S., Gerstmayer, B., Sawitzki, B., Miqueu, P., Mrazova, P., Tycova, I., Svobodova, E., et al. (2017) · PLOS ONE

Renal Transplantation Outcomes and TreatmentsTransplantation: Methods and Outcomes

Cited by 12